Population-based studies support an association between GERD and chronic cough, laryngitis, and asthma, but the causal relationship is unclear and randomized controlled trials show GERD treatment to ...
(RTTNews) - Merit Medical Systems, Inc. (MMSI), on Thursday announced that the American Society for Gastrointestinal Endoscopy or ASGE has updated its clinical practice guideline on the diagnosis and ...
The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do not achieve ...
Share on Pinterest The FDA has approved vonoprazan (Voquezna), a new daily treatment for heartburn associated with GERD in adults. andreswd/Getty Images The FDA approved vonoprazan (Voquezna) as a ...
Please provide your email address to receive an email when new articles are posted on . Proton pump inhibitors with histamine 2 receptor antagonists reduced all-cause mortality in patients with ...
SANTA ANA, Calif.--(BUSINESS WIRE)--EndoStim, a medical device company developing and commercializing a first-in-class implantable neurostimulation treatment for drug refractory gastroesophageal ...
EDEN PRAIRIE, Minn., Nov. 3, 2023 /PRNewswire/ -- Aplos Medical (formerly CT Resources), developer of the next generation Gastroesophageal Reflux Disease (GERD) treatment, proudly announces the ...
Lansoprazole Does Not Improve Asthma Control in Children Treatment with lansoprazole did not improve asthma control in children without overt gastroesophageal reflux disease (GERD), and was associated ...
The FDA approved vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal reflux disease (GERD) in adults. GERD is a condition in which acidic stomach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results